Long-term outcome of individualized prophylactic treatment of children with severe haemophilia-Reference-Cited by-同舟云学术

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

Published:2001-03 Issue:3 Volume:112 Page:561-565
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Van Den Berg H. M.,Fischer K.,Mauser-Bunschoten E. P.,Beek F. J. A.,Roosendaal G.,Van Der Bom J. G.,Nieuwenhuis H. K.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02580.x/fullpdf

Reference23 articles.

1. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group;Aledort;Journal of Internal Medicine,1994

2. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized;Astermark;British Journal of Haematology,1999

3. Cost-effectiveness - Can it be measured?;Bohn;Seminars in Hematology,1993

4. Prophylactic use of factor VIII: an economic evaluation;Bohn;Thrombosis and Haemostasis,1998

5. Long-term therapy and on-demand treatment of children and adolescents with severe haemaophilia A: 12 years of experience;Brackmann;Haemostasis,1992

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B‐LONG study;European Journal of Haematology;2024-06-25

2. Arthropathy on X-rays in 363 persons with hemophilia: long-term development, and impact of birth cohort and inhibitor status;Research and Practice in Thrombosis and Haemostasis;2024-02

3. Treatment regimens, patient reported outcomes and health-related quality of life in children with moderate and severe hemophilia A in China: using real-world data;Orphanet Journal of Rare Diseases;2023-08-04

4. Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors;Hematology Reports;2023-02-16

5. Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A;Research and Practice in Thrombosis and Haemostasis;2023-01